Literature DB >> 23017870

Different effects of carbon ion beams and X-rays on clonogenic survival and DNA repair in human pancreatic cancer stem-like cells.

Kazuhiko Oonishi1, Xing Cui, Hirokazu Hirakawa, Akira Fujimori, Takehiko Kamijo, Shigeru Yamada, Osamu Yokosuka, Tadashi Kamada.   

Abstract

PURPOSE: The effects of a carbon ion beam and X-rays on human pancreatic cancer stem-like cells were examined from the point of view of clonogenic survival and DNA repair.
MATERIALS AND METHODS: Human pancreatic cancer stem-like cells were treated with and without carbon ion and X-ray irradiation, and then colony, spheroid and tumor formation assays as well as γH2AX foci formation assay were performed.
RESULTS: The relative biological effectiveness (RBE) values of a carbon ion beam relative to X-ray for the MIA PaCa-2 and BxPc-3 cells at the D10 values were 1.85-2.10. The ability for colony, spheroid formation, and tumorigenicity from cancer stem-like CD44(+)/CD24(+) cells is significantly higher than that from non-cancer stem-like CD44(-)/CD24(-)cells. FACS data showed that CD44(+)/CD24(+) cells were more highly enriched after X-rays compared to carbon ion irradiation at isoeffective doses. The RBE values for the carbon ion beam relative to X-ray at the D10 levels for CD44(+)/CD24(+) cells were 2.0-2.19. The number of γH2AX foci in CD44(-)/CD24(-) cells was higher than that of CD44(+)/CD24(+) cells after irradiation with either X-ray or carbon ion beam. The number of γH2AX foci in CD44(+)/CD24(+) cells was almost the same in the early time, but it persists significantly longer in carbon ion beam irradiated cells compared to X-rays.
CONCLUSIONS: Carbon ion beam has superior potential to kill pancreatic cancer stem cell-like cells, and prolonged induction of DNA damage might be one of the pivotal mechanisms of its high radiobiological effects compared to X-rays.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23017870     DOI: 10.1016/j.radonc.2012.08.009

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  42 in total

Review 1.  Comparing Photon and Charged Particle Therapy Using DNA Damage Biomarkers.

Authors:  Shayoni Ray; Egle Cekanaviciute; Ivan Paulino Lima; Brita Singers Sørensen; Sylvain V Costes
Journal:  Int J Part Ther       Date:  2018-09-21

Review 2.  The Future of Combining Carbon-Ion Radiotherapy with Immunotherapy: Evidence and Progress in Mouse Models.

Authors:  Takashi Shimokawa; Liqiu Ma; Ken Ando; Katsutoshi Sato; Takashi Imai
Journal:  Int J Part Ther       Date:  2016-08-29

3.  Molecular mechanisms underlying the enhancement of carbon ion beam radiosensitivity of osteosarcoma cells by miR-29b.

Authors:  Eun Ho Kim; Jeong Yub Kim; Mi-Sook Kim; Guillaume Vares; Tatsuya Ohno; Akihisa Takahashi; Akiko Uzawa; Seung-Jun Seo; Sei Sai
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  Therapeutic potential of cancer stem cells.

Authors:  Chunguang Yang; Kunlin Jin; Yangping Tong; William Chi Cho
Journal:  Med Oncol       Date:  2015-04-25       Impact factor: 3.064

5.  Targeting head and neck cancer stem cells to overcome resistance to photon and carbon ion radiation.

Authors:  Gérald Bertrand; Mira Maalouf; Antony Boivin; Priscillia Battiston-Montagne; Michael Beuve; Antonin Levy; Patrice Jalade; Claudia Fournier; Dominique Ardail; Nicolas Magné; Gersende Alphonse; Claire Rodriguez-Lafrasse
Journal:  Stem Cell Rev Rep       Date:  2014-02       Impact factor: 5.739

Review 6.  Advanced-stage pancreatic cancer: therapy options.

Authors:  Jens Werner; Stephanie E Combs; Christoph Springfeld; Werner Hartwig; Thilo Hackert; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2013-04-30       Impact factor: 66.675

Review 7.  Charged particle therapy--optimization, challenges and future directions.

Authors:  Jay S Loeffler; Marco Durante
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

8.  Radiosensitivity index predicts for survival with adjuvant radiation in resectable pancreatic cancer.

Authors:  Tobin Strom; Sarah E Hoffe; William Fulp; Jessica Frakes; Domenico Coppola; Gregory M Springett; Mokenge P Malafa; Cynthia L Harris; Steven A Eschrich; Javier F Torres-Roca; Ravi Shridhar
Journal:  Radiother Oncol       Date:  2015-07-30       Impact factor: 6.280

9.  Combination of gold nanoparticles with low-LET irradiation: an approach to enhance DNA DSB induction in HT29 colorectal cancer stem-like cells.

Authors:  Mahdi Abbasian; Azam Baharlouei; Zahra Arab-Bafrani; David A Lightfoot
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-19       Impact factor: 4.553

Review 10.  New physical approaches to treat cancer stem cells: a review.

Authors:  H Ghaffari; J Beik; A Talebi; S R Mahdavi; H Abdollahi
Journal:  Clin Transl Oncol       Date:  2018-06-04       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.